Crawshaw Jacob, McCleary Nicola
Methodological and Implementation Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Child Health Evaluative Sciences Program, The Hospital for Sick Children, Toronto, ON, Canada.
Front Pharmacol. 2025 Jul 22;16:1567967. doi: 10.3389/fphar.2025.1567967. eCollection 2025.
Medication adherence remains a global health issue and healthcare providers (HCPs) play an important role in supporting patients to adhere to treatment. This article provides a state-of-the-science overview of the evidence for: i) the effectiveness of HCP-delivered interventions on medication adherence outcomes; and ii) the types of implementation approaches targeting evidence-to-practice gaps among HCPs supporting medication adherence. Hundreds of randomized controlled trials and dozens of systematic reviews on the effectiveness of HCP-delivered interventions have been conducted to date. HCP-delivered interventions typically produce small-to-medium effect sizes on adherence outcomes, however, there is considerable heterogeneity in effects and few interventions that show promise are implemented into routine practice. Some key features of potentially effective HCP-delivered interventions include: moving beyond education-only, using multiple behaviour change strategies, tailoring interventions to different determinants of non-adherence, incorporating pharmacists and nurses to deliver interventions, providing ongoing support to patients, and addressing health system-level barriers and inequities. To improve the uptake of evidence into adherence-related clinical practice, it is likely that health systems must adapt to enable HCPs to better support adherence over time and in a patient-centered way. Such approaches include, improving routine screening of adherence issues, making adherence-related clinical guidelines more actionable, using routinely collected data to identify patients with adherence challenges, enhancing HCP incentivization models, and establishing quality indicators for adherence monitoring and support. Concepts and evidence from implementation science should be leveraged to support these types of system-level approaches to address evidence-to-practice gaps. In conclusion, despite an extensive evidence base for the effectiveness of HCP-delivered interventions - and a growing body of evidence for approaches targeting practice change among HCPs - we have identified several areas that could help advance the field. These include optimizing the content and delivery of adherence interventions, understanding how to implement effective strategies, and reaffirming the need for health system-level solutions.
药物依从性仍然是一个全球性的健康问题,医疗保健提供者(HCPs)在支持患者坚持治疗方面发挥着重要作用。本文提供了关于以下方面证据的科学现状概述:i)HCPs实施的干预措施对药物依从性结果的有效性;ii)针对支持药物依从性的HCPs中证据与实践差距的实施方法类型。迄今为止,已经进行了数百项关于HCPs实施的干预措施有效性的随机对照试验和数十项系统评价。HCPs实施的干预措施通常对依从性结果产生小到中等程度的效应量,然而,效应存在相当大的异质性,很少有显示出前景的干预措施被纳入常规实践。潜在有效的HCPs实施的干预措施的一些关键特征包括:超越单纯的教育,使用多种行为改变策略,根据不同的不依从决定因素调整干预措施,纳入药剂师和护士来实施干预措施,为患者提供持续支持,以及解决卫生系统层面的障碍和不公平现象。为了提高将证据应用于与依从性相关的临床实践的程度,卫生系统可能必须进行调整,以使HCPs能够随着时间的推移以患者为中心更好地支持依从性。这些方法包括,改善对依从性问题的常规筛查,使与依从性相关的临床指南更具可操作性,使用常规收集的数据识别存在依从性挑战的患者,加强HCP激励模式,以及建立用于依从性监测和支持的质量指标。应利用实施科学的概念和证据来支持这些类型的系统层面方法,以解决证据与实践之间的差距。总之,尽管有大量证据证明HCPs实施的干预措施的有效性——以及越来越多关于针对HCPs实践变革的方法的证据——但我们已经确定了几个有助于推动该领域发展的领域。这些领域包括优化依从性干预措施的内容和实施方式,理解如何实施有效策略,以及重申卫生系统层面解决方案的必要性。